Trends of Mycobacterium tuberculosis and rifampicin resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia.

IF 2.4 Q3 INFECTIOUS DISEASES Tropical Diseases, Travel Medicine and Vaccines Pub Date : 2020-08-28 eCollection Date: 2020-01-01 DOI:10.1186/s40794-020-00115-1
Getachew Kahsu Abay, Bahlbi Hailay Abraha
{"title":"Trends of <i>Mycobacterium tuberculosis</i> and rifampicin resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia.","authors":"Getachew Kahsu Abay,&nbsp;Bahlbi Hailay Abraha","doi":"10.1186/s40794-020-00115-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>Tuberculosis</i> is an infectious disease usually caused by <i>Mycobacterium tuberculosis</i> bacteria. The global emergence of mono- or multidrug-resistant tuberculosis and extensively drug-resistant forms of tuberculosis pose a considerable challenge to tuberculosis control programs. There has been no reliable and organized data on trends and drug resistance of <i>Mycobacterium tuberculosis</i> in the study area. Therefore, this study aimed to determine the trends of <i>Mycobacterium tuberculosis</i> and rifampicin resistance in the Adigrat General Hospital, eastern Zone of Tigrai, North Ethiopia.</p><p><strong>Methods: </strong>A hospital-based retrospective cross-sectional study was conducted at Adigrat General Hospital from January 2015 to 2018.Data was collected retrospectively from the GeneXpert<i>™</i> TB registration book using a data extraction format. Data was entered into Epi-Info 3.1 and subsequently exported and analyzed using SPSS Version 20.The results were summarized using descriptive statistics, tables, and figures. Bivariate and multi-variant regression analysis was employed to measure the association between dependent and independent variables. <i>P</i> values < 0.05 were considered statistically significant.</p><p><strong>Result: </strong>A total of 5944 <i>Mycobacterium tuberculosis</i> presumptive patients were included in the study. The majority of the study participants were male (58.1%) with participants' median age of 40.0 (IQR 26-57) years, the majority were 30-44 years. The overall positive cases of <i>Mycobacterium tuberculosis</i> was 24.3% (1446) with a total of 132 (9.1%) found to be resistant to rifampicin. Of the total confirmed positive cases 8.7% (103/1188) and 11.2% (29/258) were rifampicin resistance of presumptive tuberculosis and presumptive drug resistance tuberculosis patients respectively. Age, the reason for diagnosis, site of presumptive tuberculosis, and/or being HIV infected showed significant association with our dependent variable; however, only age and being HIV infected were associated with rifampicin resistance.</p><p><strong>Conclusion: </strong>In our study, the overall trends of <i>Mycobacterium tuberculosis</i> and rifampicin resistance were found to be high. Rifampicin resistance is more common in patients with HIV and presumptive drug resistance tuberculosis individuals. Therefore, maximizing early detection of drug-resistant and strengthening tuberculosis infection control activities are recommended to reduce the burden of this contagious and potentially deadly disease.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"6 ","pages":"14"},"PeriodicalIF":2.4000,"publicationDate":"2020-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40794-020-00115-1","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tropical Diseases, Travel Medicine and Vaccines","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40794-020-00115-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 5

Abstract

Background: Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. The global emergence of mono- or multidrug-resistant tuberculosis and extensively drug-resistant forms of tuberculosis pose a considerable challenge to tuberculosis control programs. There has been no reliable and organized data on trends and drug resistance of Mycobacterium tuberculosis in the study area. Therefore, this study aimed to determine the trends of Mycobacterium tuberculosis and rifampicin resistance in the Adigrat General Hospital, eastern Zone of Tigrai, North Ethiopia.

Methods: A hospital-based retrospective cross-sectional study was conducted at Adigrat General Hospital from January 2015 to 2018.Data was collected retrospectively from the GeneXpert TB registration book using a data extraction format. Data was entered into Epi-Info 3.1 and subsequently exported and analyzed using SPSS Version 20.The results were summarized using descriptive statistics, tables, and figures. Bivariate and multi-variant regression analysis was employed to measure the association between dependent and independent variables. P values < 0.05 were considered statistically significant.

Result: A total of 5944 Mycobacterium tuberculosis presumptive patients were included in the study. The majority of the study participants were male (58.1%) with participants' median age of 40.0 (IQR 26-57) years, the majority were 30-44 years. The overall positive cases of Mycobacterium tuberculosis was 24.3% (1446) with a total of 132 (9.1%) found to be resistant to rifampicin. Of the total confirmed positive cases 8.7% (103/1188) and 11.2% (29/258) were rifampicin resistance of presumptive tuberculosis and presumptive drug resistance tuberculosis patients respectively. Age, the reason for diagnosis, site of presumptive tuberculosis, and/or being HIV infected showed significant association with our dependent variable; however, only age and being HIV infected were associated with rifampicin resistance.

Conclusion: In our study, the overall trends of Mycobacterium tuberculosis and rifampicin resistance were found to be high. Rifampicin resistance is more common in patients with HIV and presumptive drug resistance tuberculosis individuals. Therefore, maximizing early detection of drug-resistant and strengthening tuberculosis infection control activities are recommended to reduce the burden of this contagious and potentially deadly disease.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
埃塞俄比亚北部提格拉伊东部地区阿迪格拉特总医院结核分枝杆菌和利福平耐药趋势
背景:结核病是一种通常由结核分枝杆菌引起的传染病。全球出现的耐单药或耐多药结核病和广泛耐药结核病对结核病控制规划构成了相当大的挑战。在研究地区尚无可靠和有组织的结核分枝杆菌趋势和耐药数据。因此,本研究旨在确定埃塞俄比亚北部Tigrai东部地区Adigrat总医院结核分枝杆菌和利福平耐药性的趋势。方法:2015年1月至2018年1月在Adigrat总医院进行回顾性横断面研究。采用数据提取格式从GeneXpert™结核病登记簿中回顾性收集数据。数据输入Epi-Info 3.1,随后导出并使用SPSS Version 20进行分析。采用描述性统计、表格和图表对结果进行总结。采用双变量和多变量回归分析来衡量因变量和自变量之间的相关性。结果:共纳入5944例推定结核分枝杆菌患者。研究对象以男性居多(58.1%),中位年龄40.0 (IQR 26-57)岁,30-44岁居多。结核分枝杆菌阳性1446例(24.3%),对利福平耐药132例(9.1%)。确诊阳性病例中,8.7%(103/1188)为推定结核利福平耐药患者,11.2%(29/258)为推定结核耐药患者。年龄、诊断原因、推定结核病的部位和/或感染艾滋病毒与我们的因变量有显著相关性;然而,只有年龄和感染艾滋病毒与利福平耐药性有关。结论:本研究结核分枝杆菌和利福平耐药总体呈高趋势。利福平耐药在艾滋病毒患者和推定耐药结核病患者中更为常见。因此,建议最大限度地早期发现耐药并加强结核病感染控制活动,以减轻这种具有传染性和潜在致命性疾病的负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.20
自引率
0.00%
发文量
25
审稿时长
17 weeks
期刊介绍: Tropical Diseases, Travel Medicine and Vaccines is an open access journal that considers basic, translational and applied research, as well as reviews and commentary, related to the prevention and management of healthcare and diseases in international travelers. Given the changes in demographic trends of travelers globally, as well as the epidemiological transitions which many countries are experiencing, the journal considers non-infectious problems including chronic disease among target populations of interest as well as infectious diseases.
期刊最新文献
Monkeypox: a re-emergent virus with global health implications - a comprehensive review. Addressing the emerging threat of Oropouche virus: implications and public health responses for healthcare systems. The application of aptamer in tuberculosis diagnosis: a systematic review. Significance of climate change in the emergence of human fascioliasis in Upper Egypt. Exploring plant-based dengue therapeutics: from laboratory to clinic.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1